HighTower Advisors
GNMK

HighTower Advisors’s GenMark Diagnostics, Inc GNMK Stock Holding History

HighTower Advisors’s Portfolio GNMK Stock Details GNMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-951,437
Closed -$13.9M – 3361
2020
Q4 		$13.9M Buy
951,437
+173,867
+22% +$2.3M 0.06% 303
2020
Q3 		$11M Sell
777,570
-198,552
-20% -$3.03M 0.05% 320
2020
Q2 		$14.4M Sell
976,122
-1,317,014
-57% -$13.4M 0.08% 247
2020
Q1 		$9.45M Buy
2,293,136
+21,300
+0.9% +$99.9K 0.06% 285
2019
Q4 		$10.9M Sell
2,271,836
-72,811
-3% -$402K 0.06% 303
2019
Q3 		$14.2M Sell
2,344,647
-267,208
-10% -$1.67M 0.08% 258
2019
Q2 		$16.9M Buy
2,611,855
+71,814
+3% +$506K 0.1% 217
2019
Q1 		$18M Buy
2,540,041
+225,110
+10% +$1.48M 0.12% 182
2018
Q4 		$11.3M Sell
2,314,931
-22,201
-0.9% -$116K 0.09% 239
2018
Q3 		$17.2M Buy
2,337,132
+21,385
+0.9% +$157K 0.12% 181
2018
Q2 		$14.8M Sell
2,315,747
-57,551
-2% -$380K 0.12% 197
2018
Q1 		$12.9M Buy
2,373,298
+17,356
+0.7% +$86.3K 0.11% 206
2017
Q4 		$9.83M Sell
2,355,942
-5,042
-0.2% -$30.3K 0.08% 266
2017
Q3 		$22.7M Hold
2,360,984
– – 0.19% 112
2017
Q2 		$27.9M Buy
2,360,984
+266,969
+13% +$3.41M 0.25% 83
2017
Q1 		$26.8M Hold
2,094,015
– – 0.26% 78
2016
Q4 		$25.6M Buy
2,094,015
+19,668
+0.9% +$234K 0.28% 72
2016
Q3 		$24.5M Buy
2,074,347
+2,028,046
+4,380% +$19.6M 0.28% 74
2016
Q2 		$403K Buy
46,301
+1,580
+4% +$10.8K 0.01% 1211
2016
Q1 		$236K Hold
44,721
– – ﹤0.01% 1736
2015
Q4 		$346K Buy
44,721
+4,188
+10% +$32.2K ﹤0.01% 1500
2015
Q3 		$319K Buy
40,533
+3,000
+8% +$27.7K ﹤0.01% 1427
2015
Q2 		$340K Buy
37,533
+8,237
+28% +$83.1K 0.01% 1149
2015
Q1 		$380K Buy
29,296
+11,298
+63% +$148K 0.01% 1162
2014
Q4 		$245K Buy
17,998
+6,093
+51% +$68.1K ﹤0.01% 1316
2014
Q3 		$107K Hold
11,905
– – ﹤0.01% 1430
2014
Q2 		$161K Hold
11,905
– – ﹤0.01% 1435
2014
Q1 		$118K Hold
11,905
– – ﹤0.01% 1372
2013
Q4 		$158K Hold
11,905
– – ﹤0.01% 1345
2013
Q3 		$145K Hold
11,905
– – ﹤0.01% 1194
2013
Q2 		$123K Buy
+11,905
New +$164K ﹤0.01% 1172

Other funds holding GNMK

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VI
Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HighTower Advisors's GNMK Position: Q1 2021 in Review

HighTower Advisors sold out of GenMark Diagnostics, Inc (GNMK) in Q1 2021, closing a stake of 951,437 shares — an estimated $13.9M sold.

HighTower Advisors first reported a position in GNMK in Q2 2013 and held it in 31 quarters. The position peaked at $27.9M in Q2 2017. 164 funds tracked by Wall St. Rank hold GNMK as of Q1 2021.

  • HighTower Advisors reported no remaining GenMark Diagnostics, Inc position as of Q1 2021 after selling out during the quarter.
  • HighTower Advisors sold 951,437 GenMark Diagnostics, Inc shares in Q1 2021, an estimated $13.9M.
  • HighTower Advisors first reported a position in GenMark Diagnostics, Inc in Q2 2013 and held it in 31 quarters.
  • HighTower Advisors's GenMark Diagnostics, Inc position peaked at $27.9M in Q2 2017.
  • 164 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q1 2021.

Based on HighTower Advisors's 13F filing for Q1 2021, filed 10 May 2021.